Series D+-stage Healthcare AI investors
Healthcare AI investors writing series d+-stage checks. Cross-referenced with portfolio holdings, sub-vertical focus, and check-size range so you can shortlist credible leads for your raise.
Series D and subsequent funding rounds are highly advanced capital injections utilized by mature, pre-IPO companies. Startups raise these mega-rounds to finalize strategic acquisitions, weather unfavorable public market conditions, or achieve absolute global market dominance before executing a highly anticipated initial public offering or corporate sale.
63
investors match
Within Series D+: top healthcare sub-verticals
New Enterprise Associates (NEA)
VC
T1
AI/ML in Healthcare
Biotech
New Leaf Venture Partners
VC
T3
Biotech
Diagnostics
Norwest Venture Partners
VC
T3
Biotech
Care Delivery / Tech-Enabled Services
Novartis Venture Fund
Corporate VC
T1
Biotech
Pharma / Therapeutics
Novo Holdings
Corporate VC
AI
T3
Biotech
Life Sciences Tools
Oak HC/FT
VC
T1
AI/ML in Healthcare
Care Delivery / Tech-Enabled Services
Optum Ventures
Corporate VC
T1
AI/ML in Healthcare
Care Delivery / Tech-Enabled Services
OrbiMed
VC
T1
Biotech
Care Delivery / Tech-Enabled Services
OSF HealthCare Ventures
Corporate VC
T3
AI/ML in Healthcare
Care Delivery / Tech-Enabled Services
Oxford Finance LLC
PE
T3
Care Delivery / Tech-Enabled Services
Life Sciences Tools
Pfizer Venture Investments
Corporate VC
T3
AI/ML in Healthcare
Biotech
Pivotal Life Sciences
VC
T3
Biotech
Life Sciences Tools
Point72 Ventures
VC
T3
AI/ML in Healthcare
Care Delivery / Tech-Enabled Services
Pouyan Golshani
Family Office
AI/ML in Healthcare
Care Delivery / Tech-Enabled Services
RA Capital
VC
T1
Biotech
Diagnostics